BD Interventional appoints Peter Menziuso EVP and president.
Article excerpt
Highlighted: the sentence this signal was extracted from
BD Interventional appoints Peter Menziuso EVP and president. Tuesday, May 19, 2026 12:21 AM | Peter Menziuso | / | | / | / | FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has announced that Peter Menziuso has been named executive vice president and president, BD Interventional, effective June 1, 2026. Menziuso brings more than 30 years of global healthcare leadership experience and a strong record of driving growth through disciplined execution, BD said in an announcement. He most recently served as company group chairman of Johson & Johnson Vision, where he led a $5 billion global business with responsibility for commercial operations, R&D, supply chain, quality, finance and medical affairs, the announcement said. Over the course of his career, Menziuso has been recognized for strengthening market leadership, building high-performing teams and translating strategy into sustained performance through commercial rigor and operational excellence, BD said. While at Johnson & Johnson, he spent a substantial amount of his career focused on eye health, and served as a co-chair of the Healthcare Alliance for Patient Safety and chair of the MEDEC Diabetes Committee, Johnson & Johnson reports. In this new role, Menziuso will use his experience and ability to accelerate execution and deliver continued growth for...
Keep reading with a free account
The rest of this article, and every signal for BD, is in your free account.